# Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects

> **NCT01537653** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SAR231893 (REGN668)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01537653
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537653, "Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01537653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*